From the *Division of Global HIV and TB (DGHT), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia
†Division of Prevention Care and Treatment, Pediatric Maternal Clinical Branch (PMCB), Office of HIV/AIDS, United States Agency for International Development (USAID), Washington, D.C.
‡Department of Defense (DOD) HIV/AIDS Prevention Program, Defense Health Agency, San Diego, California
§Office of Program Quality, Office of the Global AIDS Coordinator and Health Diplomacy, U.S. State Department, Washington, D.C.
¶Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Accepted for publication October 26, 2022
The findings and conclusions are those of the author(s) and do not necessarily represent the official position of the US Centers for Disease Control and Prevention or the US Agency for International Development.
This study was supported by the US President’s Emergency Plan for AIDS Relief through the U.S. Centers for Disease Control and Prevention and the U.S. Agency for International Development.
The authors have no conflicts of interest to disclose.
J.G., M.P., E.R. and A.M. led the study design. K.B., M.H. and J.G. extracted the data. J.G. and M.H. conducted data analysis and developed visualizations. J.G., A.M. and P.S. drafted the manuscript. All co-authors reviewed the manuscript and approved the final version.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Jessica M. Gross, Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329. E-mail: [email protected].
